1-11 of 11
Richard F. Ambinder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)

Missak Haigentz, Jr, Jeannette Y. Lee, Elizabeth Y. Chiao, David M. Aboulafia, Lee Ratner, Richard F. Ambinder, Robert A. Baiocchi, Ronald T. Mitsuyasu, William Wachsman, Joseph A. Sparano, Michelle A. Rudek
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (24): 5038–5046.
https://doi.org/10.1158/1078-0432.CCR-23-1142
Published: 15 December 2023
View article titled, Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)
Open the PDF for Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087) in another window
Includes: Supplementary data
Journal Articles

AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma

Erin G. Reid, Kelly Shimabukuro, Page Moore, Richard F. Ambinder, Jack D. Bui, Semi Han, Otoniel Martínez-Maza, Dirk P. Dittmer, David Aboulafia, Elizabeth Yu Chiao, Toby Maurer, Robert Baiocchi, Ronald Mitsuyasu, William Wachsman, for the AIDS Malignancy Consortium (AMC)
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (12): 2646–2656.
https://doi.org/10.1158/1078-0432.CCR-21-0645
Published: 13 June 2022
View article titled, AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Open the PDF for AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma in another window
Includes: Supplementary data
Journal Articles

Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study

Laura E. Martínez, Shelly Lensing, Di Chang, Larry I. Magpantay, Ronald Mitsuyasu, Richard F. Ambinder, Joseph A. Sparano, Otoniel Martínez-Maza, Marta Epeldegui
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4642–4651.
https://doi.org/10.1158/1078-0432.CCR-20-4167
Published: 15 August 2021
View article titled, Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study
Open the PDF for Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study in another window
Includes: Supplementary data
Journal Articles

Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma

Erin G. Reid, Adrienne Suazo, Shelly Y. Lensing, Dirk P. Dittmer, Richard F. Ambinder, Frank Maldarelli, Robert J. Gorelick, David Aboulafia, Ronald Mitsuyasu, Mark A. Dickson, William Wachsman
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 558–565.
https://doi.org/10.1158/1078-0432.CCR-19-1044
Published: 03 February 2020
View article titled, Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma
Open the PDF for Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma in another window
Includes: Supplementary data
Journal Articles

Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone

James P. Dugan, Bradley M. Haverkos, Lynda Villagomez, Ludmila K. Martin, Mark Lustberg, John Patton, Marisa Martin, Ying Huang, Gerard Nuovo, Fengting Yan, Robert Cavaliere, Joyce Fingeroth, Shannon C. Kenney, Richard F. Ambinder, Gerard Lozanski, Pierluigi Porcu, Michael A. Caligiuri, Robert A. Baiocchi
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (14): 3273–3281.
https://doi.org/10.1158/1078-0432.CCR-17-2685
Published: 15 July 2018
View article titled, Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone
Open the PDF for Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone in another window
Includes: Supplementary data
Journal Articles

Abstract B33: A novel isoform of the major 8p22 tumor suppressor Deleted in Liver Cancer 1 (DLC1) gene with growth suppression function is frequently silenced epigenetically in multiple tumors

John S.W. Low, Qian Tao, Hwee Koon Goh, Ka Man Ng, Wan Lu Woo, Richard F. Ambinder, Gopesh Srivastava, Meir Shamay, Anthony T.C. Chan, Nicholas C. Popescu, Wen-son Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): B33.
https://doi.org/10.1158/1078-0432.TCME10-B33
Published: 02 February 2016
View article titled, Abstract B33: A novel isoform of the major 8p22 tumor suppressor <em>Deleted in Liver Cancer 1 (DLC1)</em> gene with growth suppression function is frequently silenced epigenetically in multiple tumors
Journal Articles

Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)

Marta Epeldegui, Jeannette Y. Lee, Anna C. Martínez, Daniel P. Widney, Larry I. Magpantay, Deborah Regidor, Ronald Mitsuyasu, Joseph A. Sparano, Richard F. Ambinder, Otoniel Martínez-Maza
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2): 328–336.
https://doi.org/10.1158/1078-0432.CCR-14-0466
Published: 14 January 2016
View article titled, Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)
Open the PDF for Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial) in another window
Journal Articles

A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors

Jianqing Lin, Jill Gilbert, Michelle A. Rudek, James A. Zwiebel, Steve Gore, Anchalee Jiemjit, Ming Zhao, Sharyn D. Baker, Richard F. Ambinder, James G. Herman, Ross C. Donehower, Michael A. Carducci
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6241–6249.
https://doi.org/10.1158/1078-0432.CCR-09-0567
Published: 30 September 2009
View article titled, A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors
Open the PDF for A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Evaluation of T- and NK-Cell-Targeted Therapies: Is There a Role for Rituximab Prophylaxis?

Richard F. Ambinder
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2205–2206.
https://doi.org/10.1158/1078-0432.CCR-08-2905
Published: 01 April 2009
View article titled, Evaluation of T- and NK-Cell-Targeted Therapies: Is There a Role for Rituximab Prophylaxis?
Open the PDF for Evaluation of T- and NK-Cell-Targeted Therapies: Is There a Role for Rituximab Prophylaxis? in another window
Includes: Supplementary data
Journal Articles

Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients with Relapsed B-Cell Lymphoma Treated with Rituximab

Jesús G. Berdeja, Allan Hess, David M. Lucas, Paul O'Donnell, Richard F. Ambinder, Louis F. Diehl, Denise Carter-Brookins, Susan Newton, Ian W. Flinn
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (8): 2392–2399.
https://doi.org/10.1158/1078-0432.CCR-06-1860
Published: 16 April 2007
View article titled, Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients with Relapsed B-Cell Lymphoma Treated with Rituximab
Open the PDF for Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients with Relapsed B-Cell Lymphoma Treated with Rituximab in another window
Journal Articles

Virus-Associated Tumor Imaging by Induction of Viral Gene Expression

De-Xue Fu, Yvette C. Tanhehco, Jianmeng Chen, Catherine A. Foss, James J. Fox, Victor Lemas, Ja-Mun Chong, Richard F. Ambinder, Martin G. Pomper
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (5): 1453–1458.
https://doi.org/10.1158/1078-0432.CCR-06-2295
Published: 01 March 2007
View article titled, Virus-Associated Tumor Imaging by Induction of Viral Gene Expression
Open the PDF for Virus-Associated Tumor Imaging by Induction of Viral Gene Expression in another window